Product Pipeline | CaPTHymone™ (BN003) | Capsitonin™ (BN002) | Selective TNF/IL6 Downregulator (BN006)

Bone Cell Regulators (BN005/008) | Joint Protection & Collagen Tolerance Programme (BN007)

 
 

CaPTHymone™
(Osteoporosis)

Parathyroid hormone (PTH) is one of the body’s principal controlling agents for the maintenance of normal calcium levels in the blood. An effective oral PTH could replace injected PTH (current global sales of $1billion), and expand the market through greater patient acceptance.

Currently, injectable PTH is the only product in the world accepted by the US Food & Drug Administration (FDA) to be able to build bone.

CaPTHymone™ (BN003 oral PTH) contains no new chemical entities and uses the same novel, proprietary oral peptide formulation and delivery system as Capsitonin™ (BN002 oral calcitonin).